Associations of treatment with hypnotics with suicide and attempted suicide: A nationwide cohort study

<p><strong>Background:</strong> Hypnotics have been linked to suicidal behaviors. While existing evidence has established findings of associations, more knowledge is needed regarding benzodiazepine (BZD) and non-benzodiazepine (n-BZD) hypnotics.</p> <p><strong>Ai...

Full description

Bibliographic Details
Main Authors: Høier, NK, Madsen, T, Spira, AP, Hawton, K, Jennum, P, Nordentoft, M, Erlangsen, A
Format: Journal article
Language:English
Published: SAGE Publications 2025
_version_ 1824459181857439744
author Høier, NK
Madsen, T
Spira, AP
Hawton, K
Jennum, P
Nordentoft, M
Erlangsen, A
author_facet Høier, NK
Madsen, T
Spira, AP
Hawton, K
Jennum, P
Nordentoft, M
Erlangsen, A
author_sort Høier, NK
collection OXFORD
description <p><strong>Background:</strong> Hypnotics have been linked to suicidal behaviors. While existing evidence has established findings of associations, more knowledge is needed regarding benzodiazepine (BZD) and non-benzodiazepine (n-BZD) hypnotics.</p> <p><strong>Aim:</strong> To examine whether individuals in treatment with hypnotics had higher rates of suicide and suicide attempts than those not in treatment..</p> <p><strong>Methods:</strong> A longitudinal nationwide cohort design was applied to individual-level register data, including all individuals aged 15+ years who lived in Denmark from 1995 to 2021. Incidence rate ratios (IRR) for suicide and suicide attempts were estimated using Poisson regression models. Using the National Prescription Registry, individuals who redeemed prescriptions for hypnotics at pharmacies were identified. Death by suicide was identified in the Cause of Death Register.</p> <p><strong>Results::</strong> A total of 7,311,630 individuals were observed over 122,681,369 person-years. In all, 678 males and 553 females died by suicide while in treatment with BZD, resulting in respective adjusted IRRs of 2.1 (95% CI: 1.9–2.4) and 2.6 (95% CI: 2.3–3.0), when compared to those not in treatment. A total of 1774 males and 1212 females died by suicide while in treatment with n-BZD and the adjusted IRRs were 3.4 (95% CI: 3.1–3.7) and 3.6 (95% CI: 3.4–3.9), respectively.</p> <p><strong>Conclusions::</strong> While confounding by indication is likely to be a major contributor, the fact that individuals in treatment with BZD or n-BZDs had higher rates of suicide and suicide attempts when compared to those not in treatment emphasizes the need to carefully monitor their mental state.</p>
first_indexed 2025-02-19T04:37:43Z
format Journal article
id oxford-uuid:490f551e-bb7e-4b50-b942-57392177c18b
institution University of Oxford
language English
last_indexed 2025-02-19T04:37:43Z
publishDate 2025
publisher SAGE Publications
record_format dspace
spelling oxford-uuid:490f551e-bb7e-4b50-b942-57392177c18b2025-02-10T11:17:56ZAssociations of treatment with hypnotics with suicide and attempted suicide: A nationwide cohort studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:490f551e-bb7e-4b50-b942-57392177c18bEnglishSymplectic ElementsSAGE Publications2025Høier, NKMadsen, TSpira, APHawton, KJennum, PNordentoft, MErlangsen, A<p><strong>Background:</strong> Hypnotics have been linked to suicidal behaviors. While existing evidence has established findings of associations, more knowledge is needed regarding benzodiazepine (BZD) and non-benzodiazepine (n-BZD) hypnotics.</p> <p><strong>Aim:</strong> To examine whether individuals in treatment with hypnotics had higher rates of suicide and suicide attempts than those not in treatment..</p> <p><strong>Methods:</strong> A longitudinal nationwide cohort design was applied to individual-level register data, including all individuals aged 15+ years who lived in Denmark from 1995 to 2021. Incidence rate ratios (IRR) for suicide and suicide attempts were estimated using Poisson regression models. Using the National Prescription Registry, individuals who redeemed prescriptions for hypnotics at pharmacies were identified. Death by suicide was identified in the Cause of Death Register.</p> <p><strong>Results::</strong> A total of 7,311,630 individuals were observed over 122,681,369 person-years. In all, 678 males and 553 females died by suicide while in treatment with BZD, resulting in respective adjusted IRRs of 2.1 (95% CI: 1.9–2.4) and 2.6 (95% CI: 2.3–3.0), when compared to those not in treatment. A total of 1774 males and 1212 females died by suicide while in treatment with n-BZD and the adjusted IRRs were 3.4 (95% CI: 3.1–3.7) and 3.6 (95% CI: 3.4–3.9), respectively.</p> <p><strong>Conclusions::</strong> While confounding by indication is likely to be a major contributor, the fact that individuals in treatment with BZD or n-BZDs had higher rates of suicide and suicide attempts when compared to those not in treatment emphasizes the need to carefully monitor their mental state.</p>
spellingShingle Høier, NK
Madsen, T
Spira, AP
Hawton, K
Jennum, P
Nordentoft, M
Erlangsen, A
Associations of treatment with hypnotics with suicide and attempted suicide: A nationwide cohort study
title Associations of treatment with hypnotics with suicide and attempted suicide: A nationwide cohort study
title_full Associations of treatment with hypnotics with suicide and attempted suicide: A nationwide cohort study
title_fullStr Associations of treatment with hypnotics with suicide and attempted suicide: A nationwide cohort study
title_full_unstemmed Associations of treatment with hypnotics with suicide and attempted suicide: A nationwide cohort study
title_short Associations of treatment with hypnotics with suicide and attempted suicide: A nationwide cohort study
title_sort associations of treatment with hypnotics with suicide and attempted suicide a nationwide cohort study
work_keys_str_mv AT høiernk associationsoftreatmentwithhypnoticswithsuicideandattemptedsuicideanationwidecohortstudy
AT madsent associationsoftreatmentwithhypnoticswithsuicideandattemptedsuicideanationwidecohortstudy
AT spiraap associationsoftreatmentwithhypnoticswithsuicideandattemptedsuicideanationwidecohortstudy
AT hawtonk associationsoftreatmentwithhypnoticswithsuicideandattemptedsuicideanationwidecohortstudy
AT jennump associationsoftreatmentwithhypnoticswithsuicideandattemptedsuicideanationwidecohortstudy
AT nordentoftm associationsoftreatmentwithhypnoticswithsuicideandattemptedsuicideanationwidecohortstudy
AT erlangsena associationsoftreatmentwithhypnoticswithsuicideandattemptedsuicideanationwidecohortstudy